Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA vaccines: The future of prevention of viral infections?
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Recent Advancement in mRNA Vaccine Development and Applications
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 55
Human circulating and tissue-resident memory CD8+ T cells
Marcus Buggert, David A. Price, Laura K. Mackay, et al.
Nature Immunology (2023) Vol. 24, Iss. 7, pp. 1076-1086
Open Access | Times Cited: 44
mRNA Technology in Modern Medicine: Review and Future Prospects
Heslley Machado Silva
Deleted Journal (2025) Vol. 2, pp. 1-1
Closed Access | Times Cited: 1
Overview of autoantibodies in COVID‐19 convalescents
Krystyna Dobrowolska, Dorota Zarębska‐Michaluk, Barbara Poniedziałek, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 24
The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
Fatemeh Movahed, Satinik Darzi, Parya Mahdavi, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Nipah Virus: A Multidimensional Update
Javier Faus-Cotino, Gabriel Reina, J. Pueyo
Viruses (2024) Vol. 16, Iss. 2, pp. 179-179
Open Access | Times Cited: 10
Generating prophylactic immunity against arboviruses in vertebrates and invertebrates
Daniel J. Rawle, Leon E. Hugo, Abigail L. Cox, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 621-636
Closed Access | Times Cited: 9
A review on Zika vaccine development
Zhe‐Yu Peng, Yang Song, Hong‐Zheng Lu, et al.
Pathogens and Disease (2024) Vol. 82
Open Access | Times Cited: 8
Research progress on the quality control of mRNA vaccines
Chaoying Hu, Yu Bai, Jianyang Liu, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 570-583
Open Access | Times Cited: 8
Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1502-1502
Open Access | Times Cited: 19
mRNA vaccines against respiratory viruses
Jennifer A. Whitaker, Hana M. El Sahly, C. Mary Healy
Current Opinion in Infectious Diseases (2023) Vol. 36, Iss. 5, pp. 385-393
Closed Access | Times Cited: 17
Components, Formulations, Deliveries, and Combinations of Tumor Vaccines
Tengfei Liu, Wenyan Yao, Wenyu Sun, et al.
ACS Nano (2024) Vol. 18, Iss. 29, pp. 18801-18833
Closed Access | Times Cited: 5
Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update
Elisa Ruiz-Arabi, Julián Torre-Cisneros, Victoria Aguilera, et al.
Transplantation Reviews (2024) Vol. 38, Iss. 4, pp. 100875-100875
Open Access | Times Cited: 5
Lipid-based nanoparticles for nucleic acids delivery
Sonia Sarnelli, Michael Cardamone, Ernesto Reverchon, et al.
Physical Sciences Reviews (2025)
Closed Access
An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits
Joshua J. Tu, Emily King, Victoria Maksimova, et al.
Journal of Virology (2024) Vol. 98, Iss. 2
Open Access | Times Cited: 4
Respiratory syncytial virus immunoprophylaxis: Novel opportunities and a call for equity
Piotr Rzymski, Willis Gwenzi
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Closed Access | Times Cited: 4
Impact of the COVID-19 Pandemic on Attitudes toward Vaccination: Representative Study of Polish Society
Tomasz Sobierajski, Piotr Rzymski, Monika Wanke-Rytt
Vaccines (2023) Vol. 11, Iss. 6, pp. 1069-1069
Open Access | Times Cited: 11
Gene-Editing and RNA Interference in Treating Hepatitis B: A Review
Nadiia Kasianchuk, Krystyna Dobrowolska, Sofiia Harkava, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2395-2395
Open Access | Times Cited: 11
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine
Annalisa Ciabattini, G Pastore, Simone Lucchesi, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1706-1706
Open Access | Times Cited: 10
In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
Alexey D. Perenkov, Alena D. Sergeeva, Maria V. Vedunova, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1600-1600
Open Access | Times Cited: 10
Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches
Piotr Rzymski, Aliyu Tijani Jibril, Laila Rahmah, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 9
Closed Access | Times Cited: 3
Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors
Piotr Rzymski
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Towards broad-spectrum protection: the development and challenges of combined respiratory virus vaccines
Yang Wang, Xiaotong Wei, Yang Liu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
mRNA vaccine development and applications: A special focus on tumors (Review)
Bangjie Chen, Yipin Yang, Xinyi Wang, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 2
Closed Access | Times Cited: 2
Examining the potentials of stem cell therapy in reducing the burden of selected non-communicable diseases in Africa
Faith Ayobami Atewologun, Olalekan John Okesanya, Inibehe Ime Okon, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top